HOME >> MEDICINE >> NEWS
Emselex(R) receives positive CHMP opinion for the treatment of overactive bladder

Basel, 30th July 2004 Novartis Pharma AG announced today that the Committee for Medicinal Products for Human Use (CHMP), adopted a positive opinion recommending that the European Commission (EC) grant a Marketing Authorisation for Emselex (darifenacin hydrobromide), 7.5mg and 15mg, for the treatment of overactive bladder (OAB) in all 25 European Union (EU) countries as well as Norway and Iceland. Upon receipt of the EC approval, Novartis will be able to market Emselex throughout these countries.

"We are delighted by the CHMP's positive opinion for Emselex, to provide overactive bladder sufferers with a new safe and effective treatment option", said Jrg Reinhardt, Global Head of Development Novartis Pharma AG. "Due to its M3 selectivity, Emselex provides effective overactive bladder symptom relief while decreasing the potential risk of safety issues such as cognitive impairment or effects on cardiac function."

OAB affects almost one in six adults in Europe1. Symptoms of overactive bladder are urinary urgency (a sudden compelling desire to pass urine, which is difficult to defer) with or without urge incontinence (involuntary leakage accompanied by urgency), urinary frequency (voiding the bladder too often), and nocturia (waking at night one or more times to void the bladder).

The CHMP based its positive opinion on Emselex's comprehensive data package for OAB. The safety and efficacy of Emselex has been extensively studied in over 90 pre-clinical studies and clinical trials, involving more than 5,000 patients. Pivotal studies explored key endpoints including the reduction in the number of incontinence episodes per week, the reduction in the number of voluntary urination episodes (micturition) per day, the reduction in the episodes and severity of urgency and an increase in the average volume of urine passed per micturition.

The phase III clinical
'"/>


30-Jul-2004


Page: 1 2 3

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2018)... ... September 24, 2018 , ... A study recently published in STEM CELLS suggests ... inflammation in a painful type of skin disorder called recessive dystrophic epidermolysis bullosa (RDEB). ... RDEB, from forming. , An estimated 25,000 people in the United States alone live ...
(Date:9/23/2018)... LEXINGTON, Mass. (PRWEB) , ... ... ... a management consulting firm that specializes in working with healthcare, small business ... participate in the Massachusetts Delivery System Reform Incentive Payment (DSRIP) Technical Assistance ...
(Date:9/22/2018)... ... September 21, 2018 , ... Located on the fourth floor in ... inpatient hospice unit on Monday, October 1. The 8,500 square-foot unit featuring 16 private ... excited to partner with an organization like TGH that provides excellent, innovative care,” said ...
(Date:9/15/2018)... ... 2018 , ... ShareNote, one of the nation’s leading web-based ... Live" September, 17-18, 2018 at the Nopsi Hotel to ensure its customers have ... in the midst of Louisiana’s Medicaid budget crisis. Lt. General Russel L. Honoré, ...
(Date:9/13/2018)... ... September 13, 2018 , ... The Kelly Foundation ... operates the largest shelter for women and children experiencing homelessness in the Sacramento region. ... developed to keep the red doors of Saint John’s open after the County of ...
Breaking Medicine News(10 mins):
(Date:9/24/2018)... ... 24, 2018 , ... GlobalMed Logistix (GMLx) , a ... is announcing the 21,000 square foot expansion of its Atlanta-based headquarters located at ... partnerships with both startup and mid-size medical device manufacturers from all over the ...
(Date:9/22/2018)... and DALLAS (PRWEB) , ... September 21, 2018 ... ... HRE professionals need to stay “ahead of the curve” and understand how the ... Real Estate Conference will be held Sept. 26-27 at the Westin Galleria Dallas ...
(Date:9/15/2018)... ... 14, 2018 , ... "As of Thursday, Sept. 13, 2018, Cedar Point, North ... am planning this Women of Influence tour with the knowledge that my home will ... have to hold onto my faith through this storm. So many lives are being ...
Breaking Medicine Technology:
Cached News: